GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theranexus SA (XPAR:ALTHX) » Definitions » FCF Yield %

Theranexus (XPAR:ALTHX) FCF Yield % : -75.87 (As of May. 22, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Theranexus FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Theranexus's Trailing 12-Month Free Cash Flow is €-6.40 Mil, and Market Cap is €8.44 Mil. Therefore, Theranexus's FCF Yield % for today is -75.87%.

The historical rank and industry rank for Theranexus's FCF Yield % or its related term are showing as below:

XPAR:ALTHX' s FCF Yield % Range Over the Past 10 Years
Min: -121.91   Med: 0   Max: 0
Current: -75.87


XPAR:ALTHX's FCF Yield % is ranked worse than
82.26% of 1556 companies
in the Biotechnology industry
Industry Median: -14.16 vs XPAR:ALTHX: -75.87

Theranexus's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


Theranexus FCF Yield % Historical Data

The historical data trend for Theranexus's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theranexus FCF Yield % Chart

Theranexus Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only -64.25 -7.84 -25.48 -58.57 -73.97

Theranexus Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.87 -60.45 -48.12 -76.82 -59.27

Competitive Comparison of Theranexus's FCF Yield %

For the Biotechnology subindustry, Theranexus's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theranexus's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theranexus's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Theranexus's FCF Yield % falls into.



Theranexus FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Theranexus's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-6.402 / 8.6548784
=-73.97%

Theranexus's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-2.565 * 2 / 8.6548784
=-59.27%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Theranexus FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Theranexus FCF Yield % Related Terms

Thank you for viewing the detailed overview of Theranexus's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Theranexus (XPAR:ALTHX) Business Description

Traded in Other Exchanges
Address
60 avenue Rockefeller, Pepiniere Laennec, Lyon, FRA, 69008
Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.

Theranexus (XPAR:ALTHX) Headlines

No Headlines